Guizhou Xinbang Pharmaceutical Co Ltd (002390) — Capital Reinvestment Ratio
Guizhou Xinbang Pharmaceutical Co Ltd (002390) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥234.19 Million) in capital expenditures (CN¥10.43 Million). See 002390 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guizhou Xinbang Pharmaceutical Co Ltd Capital Reinvestment Ratio (2006–2024)
This chart tracks Guizhou Xinbang Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)
Year-by-year Capital Reinvestment Ratio for Guizhou Xinbang Pharmaceutical Co Ltd from 2006 to 2024. For live market cap and broader valuation context, see Guizhou Xinbang Pharmaceutical Co Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.20x | CN¥634.97 Million | CN¥124.87 Million | ▲ +14.5% |
| 2023 | 0.17x | CN¥790.62 Million | CN¥135.78 Million | ▼ -36.1% |
| 2022 | 0.27x | CN¥590.80 Million | CN¥158.78 Million | ▼ -51.5% |
| 2021 | 0.55x | CN¥457.97 Million | CN¥253.76 Million | ▲ +197.8% |
| 2020 | 0.19x | CN¥742.11 Million | CN¥138.09 Million | ▼ -20.5% |
| 2019 | 0.23x | CN¥886.33 Million | CN¥207.54 Million | ▼ -89.1% |
| 2017 | 2.16x | CN¥201.74 Million | CN¥435.03 Million | ▼ -4.8% |
| 2015 | 2.27x | CN¥217.40 Million | CN¥492.48 Million | ▼ -92.4% |
| 2010 | 29.83x | CN¥2.50 Million | CN¥74.62 Million | ▲ +18640.7% |
| 2009 | 0.16x | CN¥41.75 Million | CN¥6.65 Million | ▼ -43.2% |
| 2008 | 0.28x | CN¥24.86 Million | CN¥6.97 Million | ▼ -68.5% |
| 2007 | 0.89x | CN¥32.49 Million | CN¥28.95 Million | ▼ -83.3% |
| 2006 | 5.35x | CN¥7.35 Million | CN¥39.27 Million | — |